Jennie Young

Addressing overtreatment of screen detected DCIS; the LORIS trial

Adele Francis, Jeremy Thomas, Lesley Fallowfield et al. · European Journal of Cancer · 2015 · 375 citations · Full text

Medicine, Internal Medicine, Preventive Medicine +5

Effects of the addition of gemcitabine, and paclitaxel-first sequencing, in neoadjuvant sequential epirubicin, cyclophosphamide, and paclitaxel for women with high-risk early breast cancer (Neo-tAnGo): an open-label, 2×2 factorial randomised phase 3 trial

Helena Earl, Anne-Laure Vallier, Louise Hiller et al. · The Lancet Oncology · 2013 · 119 citations · Full text

Medicine, Oncology, Pharmacology +17

MASSIVE HEMORRHAGE IN DIVERTICULOSIS

Jennie Young, M. Beckett Howorth · Annals of Surgery · 1954 · 32 citations

Medicine, Surgery, Gastroenterology +10

Addition of gemcitabine to paclitaxel, epirubicin, and cyclophosphamide adjuvant chemotherapy for women with early-stage breast cancer (tAnGo): final 10-year follow-up of an open-label, randomised, phase 3 trial

Helena Earl, Louise Hiller, Helen Howard et al. · The Lancet Oncology · 2017 · 17 citations · Full text

Medicine, Oncology, Pharmacology +11

Recruiting women with ductal carcinoma in situ to a randomised controlled trial: lessons from the LORIS study

Sally Wheelwright, Lucy Matthews, Valerie Jenkins et al. · Trials · 2023 · 16 citations · Full text

Medicine, Oncology, Cancer Control +14